Category: Prescription Drugs
Central America Prescription Drugs
-
South & Central America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... 2.7% from 2023 to 2031. Increasing Initiatives for Eye Care Awareness Fuel South & Central America Dry Eye Products Market In recent years, various initiatives have been taken to create awareness and educate people regarding ... Read More
-
2024-2029 Panama Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... provides information and analysis not available from any other published source . This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... Read More
-
South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The South & Central America epilepsy market was valued at US$ 593.56 million ... Read More
-
Epilepsy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, ... Read More
-
South & Central America Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
... Bladder) The South & Central America overactive bladder treatment market is expected to grow from US$ 472.49 million in 2022 to US$ 543.53 million by 2028; it is estimated to grow at a CAGR of ... Read More
Research Assistance
